Introducing insitro’s TherML™: Rapidly engineering the right therapeutic for the right target
The primary driver of clinical attrition in drug discovery is often not insufficient scientific rigor, it is misalignment between the biological target and the therapeutic intervention. Discovery organizations have historically structured…
Read More